Stocks · Health care · Pharmaceutical Preparations

uniQure N.V.

QURE Clue Score22
Fiscal year ends December CIK 0001590560 Results filed 4 Nov 2026

What the insiders did Net selling

By person

25 insiders · 377 transactions
35.2×

Matthew Kapusta holds 35.2 times base salary in stock. $23.83M of shares against $676.17K in salary for 2025.

Salary from the company's own proxy. The shares are what Matthew Kapusta last reported holding, valued at $45.89, the price Ordinary Shares was last bought or sold at on the open market here, on 2 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Matthew C Kapusta
CEO, Managing Director
—
$50.18M (138) scheduled
−$50.18M
519,227
0.7485%
$23.83M
+125.2%
Alexander Edward Kuta III
Executive VP, Operations
—
$5.14M (38) scheduled
−$5.14M
90,381
0.1303%
$4.15M
—
Robert Gut
Director
—
$4.96M (24) scheduled
−$4.96M
32,259
0.0465%
$1.48M
—
Christian Klemt
Chief Financial Officer
—
$4.79M (32)
−$4.79M
226,581
0.3266%
$10.40M
+885.1%
Jack Kaye
Director
—
$2.96M (18) scheduled
−$2.96M
25,996
0.0375%
$1.19M
—
Walid Abi-Saab
Chief Medical Officer
—
$2.65M (10) scheduled
−$2.65M
166,985
0.2407%
$7.66M
+148.5%
Paula Soteropoulos
Director
—
$1.92M (19)
−$1.92M
20,203
0.0291%
$927.12K
+26.3%
Philip Astley-Sparke
Director
—
$1.51M (14)
−$1.51M
9,946
0.0143%
$456.42K
−66.8%
Madhavan Balachandran
Director
—
$1.07M (13) scheduled
−$1.07M
43,254
0.0624%
$1.98M
—
Steven Zelenkofske
Chief Medical Officer
—
$888.72K (1)
−$888.72K
159,458
0.2299%
$7.32M
—
Harald Petry
Chief Scientific Officer
—
$846.06K (6) scheduled
−$846.06K
0
0.0000%
$0.00
—
Ricardo Dolmetsch
President, R&D
—
$590.56K (6)
−$590.56K
163,404
0.2356%
$7.50M
—
Pierre Caloz
Chief Operating Officer
—
$574.06K (9)
−$574.06K
115,707
0.1668%
$5.31M
—
Kylie O'Keefe
Chief Customer & Strat Officer
—
$431.23K (1)
−$431.23K
108,864
0.1569%
$5.00M
+3.7%
Jeannette Potts
Chief Legal Officer
—
$428.50K (6)
−$428.50K
133,246
0.1921%
$6.11M
—
David Schaffer
Director
—
$371.73K (4)
−$371.73K
46,978
0.0677%
$2.16M
−12.0%
Deventer Sander van
EVP, Research & Product Dev.
—
$290.64K (4)
−$290.64K
102,512
0.1478%
$4.70M
+88.7%
Jeremy P. Springhorn
Director
—
$263.95K (10)
−$263.95K
43,251
0.0624%
$1.98M
—
David D. Meek
Director
—
$220.59K (9)
−$220.59K
39,747
0.0573%
$1.82M
—
Leonard E Post
Director
—
$159.91K (6)
−$159.91K
35,494
0.0512%
$1.63M
—
Rachelle Suzanne Jacques
Director
—
$146.72K (5)
−$146.72K
33,903
0.0489%
$1.56M
—
Maria E Cantor
SVP, Investor Rel. & Comm.
—
$118.03K (1)
−$118.03K
92,439
0.1333%
$4.24M
+164.1%
Paul E Firuta
Chief Commercial Officer
—
$118.03K (1)
−$118.03K
93,817
0.1352%
$4.31M
+168.0%
Jonathan Garen
Chief Business Officer
—
$118.03K (1)
−$118.03K
93,638
0.1350%
$4.30M
+167.5%
Scott T. McMillan
Chief Operating Officer
—
$18.46K (1)
−$18.46K
20,432
0.0295%
$937.62K
+16,786%